Filing Flows

Filing Flows › Comparisons › CURLF vs USNA

Curaleaf Holdings vs Usana Health Sciences: CURLF and USNA compared

Curaleaf Holdings is the larger company: $353M of revenue in its latest quarter (Q3 2026) against $223M for Usana Health Sciences (Q2 2026). Curaleaf Holdings is growing faster (+11% against -5% a year earlier). Curaleaf Holdings is more profitable, with an operating margin of 0.8% against -9.0%.

Curaleaf Holdings vs Usana Health Sciences, latest quarterCuraleaf Holdings vs Usana Health Sciences, latest quarterCuraleaf Holdings (CURLF)Usana Health Sciences (USNA)Revenue$353M$223MRevenue growth, Y/Y+11%-5%Operating margin0.8%-9.0%Net margin-9.3%-12.5%Free cash flow$4.0M$20.2M

Where the money goes: CURLF and USNA

Curaleaf Holdings (CURLF) · Q3 2026

Curaleaf Holdings, Q3 2026: revenue $353M (+11% year over year), operating margin 0.8%, net loss $32.7M, operating cash flow $21.1M. The chart follows the revenue to costs, profit and cash.

Usana Health Sciences (USNA) · Q2 2026

Usana Health Sciences, Q2 2026: revenue $223M (-5% year over year), operating margin -9.0%, net loss $28.0M, operating cash flow $23.3M. The chart follows the revenue to costs, profit and cash.

Curaleaf Holdings revenue by segment, Q3 2026Curaleaf Holdings revenue by segment, Q3 2026Retail and wholesale revenues$349MManagement fee income$3.9M
Curaleaf Holdings (CURLF)Usana Health Sciences (USNA)
Latest quarterQ3 2026Q2 2026
Revenue$353M$223M
Revenue growth, Y/Y+11%-5%
Operating margin0.8%-9.0%
Net earnings−$32.7M−$28.0M
Net margin-9.3%-12.5%
Operating cash flow$21.1M$23.3M
Free cash flow$4.0M$20.2M
Market value$2.5B$276M
Analysts’ mean target$16.00$25.00

Where the revenue comes from

Curaleaf Holdings

Questions

Which is bigger, Curaleaf Holdings or Usana Health Sciences?

Curaleaf Holdings is the larger company: $353M of revenue in its latest quarter (Q3 2026) against $223M for Usana Health Sciences (Q2 2026).

Is Curaleaf Holdings or Usana Health Sciences growing faster?

Curaleaf Holdings is growing faster (+11% against -5% a year earlier).

Which is more profitable, Curaleaf Holdings or Usana Health Sciences?

Curaleaf Holdings is more profitable, with an operating margin of 0.8% against -9.0%.

More: Curaleaf Holdings earnings · how Curaleaf Holdings makes money · Usana Health Sciences earnings · how Usana Health Sciences makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.